bromfenac has been researched along with Macular Edema in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 8 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Visco, DM | 1 |
| Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW | 1 |
| Babazono, T; Endo, N; Hirose, A; Kitano, S; Ogihara, R; Takeda, R; Tobimatsu, Y | 1 |
| Elbarawy, AA; Gabr, AF; Kamel, MF | 1 |
| Baek, SK; Lee, MW; Lee, YH; Song, SH | 1 |
| Hess, J; Kauffman, L; Walter, K | 1 |
| García-Arzate, D; García-Sánchez, GA; García-Santisteban, R; Gonzalez-Salinas, R; Hernández-Piñamora, E; Linares-Alba, MA; Morales-Cantón, V; Quiroz-Mercado, H; Rodríguez-Reyes, AA; Sánchez-Santos, I; Tirado-González, V | 1 |
| Cimino, L; Coassin, M; De Maria, M; Fontana, L; Iannetta, D; Mastrofilippo, V | 1 |
| Campa, C; Perri, P; Salsini, G | 1 |
| Amon, M; Findl, O; Goslings, WRO; Güell, JL; Henry, YP; Joosse, MV; Kohnen, T; Murta, JCN; Nuijts, RMMA; Rulo, AHF; Schouten, JSAG; Tassignon, MJ; van den Biggelaar, FJHM; Veldhuizen, CA; Wielders, LHP; Winkens, B | 1 |
| Campos, EC; Finzi, A; Giannaccare, G; Greco, F; Sebastiani, S; Versura, P | 1 |
| Amon, M; Findl, O; Goslings, WRO; Henry, YP; Joosse, MV; Kohnen, T; Murta, JCN; Nagy, ZZ; Nuijts, RMMA; Rulo, AHF; Schouten, JSAG; Tassignon, MJ; van den Biggelaar, FJHM; Veldhuizen, CA; Wielders, LHP; Winkens, B | 1 |
| Hieda, O; Inatomi, T; Kayukawa, K; Kinoshita, S; Kitazawa, K; Mori, K; Sotozono, C; Wakimasu, K | 1 |
| Chen, PQ; Jin, CF; Shentu, XC; Wang, QW; Weng, Y; Wu, W; Xie, X; Xu, W; Yao, K; Yu, YH; Zhang, L; Zhu, YN | 1 |
| Abu Al-Fadl, EM; Arcinue, CA; Artornsombudh, P; Foster, CS; Radwan, AE; Yang, P | 1 |
| Duong, HV; Singleton, IC; Westfield, KC | 1 |
| Shimura, M; Yasuda, K | 1 |
| Maruyama, Y; Masuda, A; Miyata, K; Nejima, R; Terada, Y | 1 |
| Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY | 1 |
| Blasetti, F; Boscia, F; Pinna, A; Ricci, GD | 1 |
| Kato, S; Maruyama, Y; Miyai, T; Miyanaga, M; Miyata, K; Nejima, R | 1 |
| Endo, N; Haruyama, K; Kato, S; Kitano, S; Shoji, M | 1 |
| Francis, P; Jones, J | 1 |
| Bahrani, H; Fox, JE; Warren, KA | 1 |
2 review(s) available for bromfenac and Macular Edema
| Article | Year |
|---|---|
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract Extraction; Dexamethasone; Diclofenac; Fluorometholone; Humans; Macular Edema; Treatment Outcome | 2023 |
Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Cells, Cultured; Conjunctivitis, Allergic; Eye Diseases; Humans; Macular Edema; Miosis; Ophthalmic Solutions; Pain, Postoperative; Toxicity Tests; Treatment Outcome; Uveitis, Anterior | 2009 |
13 trial(s) available for bromfenac and Macular Edema
| Article | Year |
|---|---|
Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular Edema.
Topics: Aged; Betamethasone; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2023 |
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema.
Topics: Angiogenesis Inhibitors; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome | 2023 |
Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Ophthalmic Solutions; Phenylacetates; Prospective Studies; Pseudophakia; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Diabetes Mellitus; Female; Glucocorticoids; Humans; Macular Edema; Male; Ophthalmic Solutions; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Diclofenac; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Humans; Instillation, Drug; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bevacizumab; Bromobenzenes; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intraocular; Intravitreal Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Fluorometholone; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Treatment Outcome; Uveitis | 2013 |
Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Benzophenones; Bromobenzenes; Cataract Extraction; Drug Therapy, Combination; Fluoroquinolones; Glucocorticoids; Humans; Macular Edema; Ophthalmic Solutions; Postoperative Complications; Practice Guidelines as Topic; Prednisolone; Prospective Studies; Single-Blind Method; Topoisomerase II Inhibitors; Uveitis, Anterior; Uveitis, Posterior | 2015 |
[The anti-inflammatory effect of 0.1% bromfenac and 0.1% betamethasone combination in post-cataract surgery patients with diabetes mellitus].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Benzophenones; Betamethasone; Bromobenzenes; Cataract; Cataract Extraction; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Macular Edema; Male; Middle Aged; Postoperative Complications | 2014 |
The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Female; Humans; Inflammation; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Miosis; Phacoemulsification; Postoperative Complications; Postoperative Period; Premedication; Treatment Outcome | 2015 |
Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Betamethasone; Bromobenzenes; Cataract Extraction; Cornea; Drug Therapy, Combination; Endophthalmitis; Endothelium, Corneal; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2009 |
Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2010 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
9 other study(ies) available for bromfenac and Macular Edema
| Article | Year |
|---|---|
Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Dexamethasone; Humans; Incidence; Iritis; Ketorolac; Macular Edema; Pain; Photophobia; Postoperative Complications; Retrospective Studies | 2023 |
Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2020 |
Rate of pseudophakic cystoid macular edema using intraoperative and topical nonsteroidal antiinflammatory drugs alone without steroids.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Female; Humans; Intraoperative Care; Ketorolac; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylephrine; Postoperative Care; Postoperative Complications; Pseudophakia; Retrospective Studies; Visual Acuity | 2020 |
Intravitreal bromfenac liposomal suspension (100 μg / 0.1 ml). A safety study in rabbit eyes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intravitreal Injections; Liposomes; Macula Lutea; Macular Edema; Rabbits; Suspensions; Treatment Outcome | 2020 |
Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Female; Humans; Inflammation; Lasers; Macular Edema; Male; Middle Aged; Phacoemulsification; Photometry; Postoperative Complications; Tomography, Optical Coherence | 2020 |
Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Postoperative Complications; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2013 |
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion.
Topics: Administration, Topical; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Case-Control Studies; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Retinal Vein Occlusion; Retreatment; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Fields | 2015 |
Bromfenac eyedrops in the treatment of diabetic macular edema: a pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Diabetic Retinopathy; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2017 |